Astal Laboratories Reports Q2 FY27 Consolidated Net Profit of Rs 977 Lakhs
Astal Laboratories Ltd 路 Financial Result 路 14 Nov 2026, 1:35 am
Astal Laboratories Reports Q2 FY27 Consolidated Net Profit of Rs 977 Lakhs Astal Laboratories approved unaudited results for the quarter ended 30th Sep'26. Consolidated revenue from operations stood at Rs 10,794.28 lakhs, up 7.0% QoQ from Rs 10,093.58 lakhs and significantly higher YoY compared to Rs 3,751.64 lakhs. Consolidated net profit reached Rs 977.04 lakhs (basic EPS Rs 2.231) versus Rs 942.17 lakhs in the preceding quarter and Rs 258.26 lakhs in the corresponding prior-year quarter. Standalone revenue came in at Rs 4,072.37 lakhs with standalone PAT of Rs 379.12 lakhs. Sriven Pharmachem contributed Rs 597.92 lakhs in net profit.
Original exchange filing (PDF)
More announcements from Astal Laboratories Ltd
- Submission of statement of Deviation and variation for September 2026 quarter. 路 14 Nov 2026
- Submission of outcome of the board meeting. 路 14 Nov 2026
- Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the unaudited standalone .... 路 13 Nov 2026
- Submission of Voting Results. 路 01 Oct 2026
- Submission of voting Results with scrutinizers report. 路 01 Oct 2026
- Attached. 路 30 Sept 2026
- Attached 路 30 Sept 2026
- Submission of outcome of 33rd Annual General Meeting. 路 29 Sept 2026
